Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
American Express
AXP
$224B
| $23M | 0.01% |
137,436
+33,980
| +33% | +$5.68M |
|
1177
Booz Allen Hamilton
BAH
$8.44B
| $23M | 0.01% |
289,689
+50,521
| +21% | +$4.22M |
|
1178
PUT
TransDigm Group
TDG
$70.7B
| $23M | 0.01% |
36,800
+5,500
| +18% | +$3.44M |
|
1179
TransUnion
TRU
$16B
| $23M | 0.01% |
204,639
+8,007
| +4% | +$941K |
|
1180
PUT
ARK Innovation ETF
ARKK
$5.59B
| $22.9M | 0.01% |
207,500
-324,400
| -61% | -$39.1M |
|
1181
Norwegian Cruise Line
NCLH
$9.53B
| $22.9M | 0.01% |
858,358
+312,374
| +57% | +$7.95M |
|
1182
Repay Holdings
RPAY
$335M
| $22.9M | 0.01% |
994,681
-349,817
| -26% | -$8.21M |
|
1183
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
| $22.9M | 0.01% |
609,795
-1,031,665
| -63% | -$38.6M |
|
|
ENJY
1184
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
| $22.9M | 0.01% |
2,289,134
+701,998
| +44% | +$6.96M |
|
1185
CALL
Edwards Lifesciences
EW
$49.4B
| $22.9M | 0.01% |
202,000
-19,500
| -9% | -$2.23M |
|
1186
e.l.f. Beauty
ELF
$4.77B
| $22.8M | 0.01% |
785,899
-7,534
| -0.9% | -$216K |
|
1187
Broadcom
AVGO
$1.76T
| $22.8M | 0.01% |
470,090
+39,230
| +9% | +$1.91M |
|
|
ABMD
1188
CALL
DELISTED
Abiomed Inc
ABMD
| $22.8M | 0.01% |
70,000
+5,000
| +8% | +$1.69M |
|
|
EVRI
1189
DELISTED
Everi Holdings
EVRI
| $22.8M | 0.01% |
941,162
+367,197
| +64% | +$8.39M |
|
1190
SPDR Gold Trust
GLD
$131B
| $22.7M | 0.01% |
138,426
+35,861
| +35% | +$6M |
|
|
MAAC
1191
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
| $22.7M | 0.01% |
2,430,346
+901,246
| +59% | +$8.95M |
|
1192
VanEck Oil Services ETF
OIH
$1.97B
| $22.7M | 0.01% |
115,312
+100,108
| +658% | +$19.1M |
|
|
TETC
1193
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
| $22.7M | 0.01% |
2,323,229
+1,145,100
| +97% | +$11.1M |
|
|
KVSC
1194
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $22.7M | 0.01% |
2,315,754
-558,094
| -19% | -$5.49M |
|
1195
Freshworks
FRSH
$3.21B
| $22.7M | 0.01% |
+530,736
| New | +$23.8M |
|
1196
United Rentals
URI
$65.7B
| $22.7M | 0.01% |
64,550
-73,644
| -53% | -$24.7M |
|
1197
CALL
Teva Pharmaceuticals
TEVA
$40.4B
| $22.6M | 0.01% |
2,323,600
+2,023,600
| +675% | +$18.9M |
|
1198
GSK
GSK
$107B
| $22.6M | 0.01% |
472,369
-217,334
| -32% | -$10.9M |
|
1199
CareDx
CDNA
$1.83B
| $22.5M | 0.01% |
354,650
-189,512
| -35% | -$14.4M |
|
1200
Entergy
ETR
$50.3B
| $22.5M | 0.01% |
452,604
-2,080,682
| -82% | -$111M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.